Respiratory syncytial virus infection in children with neuromuscular impairment

Open Microbiology Journal

Volumn 5, Issue SPEC. ISSUE 2, 2011, Pages 155-158

  Simon, Arne ^a   Prusseit, Julia ^a   Müller, Andreas ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

AIRWAY OBSTRUCTION; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILD HEALTH CARE; COUGHING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; GESTATIONAL AGE; HIGH RISK INFANT; HOSPITAL INFECTION; HUMAN; INFANT MORTALITY; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE; LENGTH OF STAY; NEUROMUSCULAR DISEASE; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; SEIZURE;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84855728162     PISSN: None     EISSN: 18742858     Source Type: Journal    
DOI: 10.2174/1874285801105010155     Document Type: Article

References (28)

1. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J 2003; 22: S40-4; discussion S44-5.
2. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-6.
3. Simon A, Ammann RA, Wilkesmann A, et al. Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database. Eur J Pediatr 2007; 166: 1273-83.
4. Meissner HC, Long SS. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Paediatrics 2003; 112: 1447-52.
5. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003; 143: S118-26.
6. Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JP. Respiratory syncytial virus infections in the paediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med 2001; 2: 318-23.
7. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003; 143: 532-40.
8. American Academy of Paediatrics. Policy statement: Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus infections. Paediatrics 2003; 112: 1442-6.
9. Panitch HB. Viral respiratory infections in children with technology dependence and neuromuscular disorders. Pediatr Infect Dis J 2004; 23: S222-7.
10. Resch B, Manzoni P, Lanari M. Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes. Paediatr Respir Rev 2009; 10: 148-53.
11. Sritippayawan S, Kun SS, Keens TG, Davidson Ward SL. Initiation of home mechanical ventilation in children with neuromuscular diseases. J Pediatr 2003; 142: 481-5.
12. Fauroux B. Special populations. Paediatr Respir Rev 2009; 10 Suppl 1: 21-2.
13. Arnold SR, Wang EE, Law BJ, et al. Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Paediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 1999; 18: 866-9.
14. Resch B, Pasnocht A, Gusenleitner W, Muller W. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age. J Infect 2005; 50: 397-403.
15. Resch B, Gusenleitner W, Muller WD, Haas J. Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29-32 weeks. Eur J Clin Microbiol Infect Dis 2006; 25: 120-2.
16. Wilkesmann A, Ammann RA, Schildgen O, et al. Hospitalized Children With Respiratory Syncytial Virus Infection and Neuromuscular Impairment Face an Increased Risk of a Complicated Course. Pediatr Infect Dis J 2007; 26: 485-91.
17. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006; 368: 312-22.
18. Panitch HB. Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction. Pediatr Infect Dis J 2003; 22: S83-87; discussion S87-8.
19. Thorburn K, Kerr S, Taylor N, van Saene HK. RSV outbreak in a paediatric intensive care unit. J Hosp Infect 2004; 57: 194-201.
20. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009; 94: 99-103.
21. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HK. High incidence of pulmonary bacterial co-infection in children with se vere respiratory syncytial virus (RSV) bronchiolitis. Thorax 2006; 61: 611-5.
22. von Renesse A, Schildgen O, Klinkenberg D, Muller A, von Moers A, Simon A. Respiratory syncytial virus infection in children admitted to hospital but ventilated mechanically for other reasons. J Med Virol 2009; 81: 160-6.
23. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005; 294: 2188-94.
24. Louie JK, Schechter R, Honarmand S, et al. Severe paediatric influenza in California, 2003-2005: implications for immunization recommendations. Paediatrics 2006; 117: e610-8.
25. Wilkesmann A, Schildgen O, Eis-Hubinger AM, et al. Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr 2006; 165: 467-75.
26. Schildgen O, Muller A, Allander T, et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev 2008; 21: 291-304.
27. Simon A, Muller A, Khurana K, et al. Nosocomial infection: A risk factor for a complicated course in children with respiratory syncytial virus infection - Results from a prospective multicenter German surveillance study. Int J Hyg Environ Health 2008; 211: 241-50.
28. Truck J. More than muscle stiffness. Schweiz Rundsch Med Prax 2006; 95: 501-4.